PharmaLectures.com

Courses › Country and business playbooks › Selling into Europe as a pharma software and AI vendor from Türkiye

Selling into Europe as a pharma software and AI vendor from Türkiye

Your Türkiye team passes the European pharma buyer's first compliance review.

  • 12 audio modulesthree lengths each
  • 2 h to 10 hbriefing to expanded
  • Workbook, transcript, certificateand a recorded quiz per module
  • Türkiye, Pharma software and AI vendorwho it is written for

Why this training matters

A quality manager at a German drugmaker asks how your software meets Annex 11, the European Union (EU) rule on computerised systems in good practice (GxP) work. Your representative has no ready answer. The review stops, and after months of meetings the deal goes to a vendor who answered.

What changes after this course

Your team answers Annex 11, Good Automated Manufacturing Practice (GAMP) 5 and General Data Protection Regulation questions in the meeting. They send the right documents that day. You hold a certificate per learner and a training record per person.

Watch the pitch

3:43 on how an audio course is bought, listened to and recorded. Full screen, one click.

Watch the pitch3:43, full screen, one click

What this course gives your people

A quality manager at a German drugmaker asks about Annex 11, and your representative answers in the meeting. The audit trail, the supplier assessment under clause 3 and the GAMP 5 category are on the table before anyone asks. Buyers stop treating your team as a software seller and start treating it as a supplier they can audit.

The Data Protection Officer's question about patient data gets a straight answer. Your team knows what Article 9 of the General Data Protection Regulation says about health data, what Chapter V requires when servers or support sit in Türkiye, and why pseudonymised data still counts as personal data. Nobody waits for legal.

Before you quote a launch date, you know whether your algorithm is a medical device. You apply Rule 11 of Annex VIII to the Medical Device Regulation, check the intended purpose, and know when the In Vitro Diagnostic Regulation applies instead. The CE marking question stops surprising your product team in the middle of a sale.

Procurement stops being a mystery. You send the vendor qualification pack and the security questionnaire complete, with the cloud hosting and data residency answers a pharma IT reviewer accepts. Your contracts carry service level and data ownership terms the buyer's legal team recognises. Your pilot projects produce results the buyer can file as evidence.

Who needs this training

  • Sales Director for European Markets

    Your representatives reach the quality head, answer the Annex 11 question in the first meeting, and stop losing deals to vendors who sound more like pharma partners.

  • Head of Artificial Intelligence Product Development

    You know whether your latest algorithm is a medical device under Rule 11 before a French or German buyer asks, and before the launch plan is built around the wrong risk class.

  • Business Development Manager

    A European procurement team returns your vendor qualification pack as incomplete. You send the full set, security questionnaire included, with contract terms on data residency and service levels that already match what they need.

  • Quality and Regulatory Affairs Lead

    You stop rewriting validation documents for each auditor. You prepare one set that answers Annex 11, shows the GAMP 5 approach, and holds up under questions on change control during an inspection.

Roles: Owner, CEO and board, Business development and export sales, Regulatory affairs, Quality assurance and Qualified Person

Businesses: Pharma software and AI vendor

Countries: Türkiye

Selling into: Europe and the UK

Courses are in English. Other languages on request.

After this course your people can

  1. Name the budget holder, the system owner and the quality approver in a European pharma company's software purchase.
  2. Answer an Annex 11 audit trail question with the exact evidence a quality manager expects.
  3. Classify your software under Rule 11 of the Medical Device Regulation and state the reasoning in writing.
  4. Reply to a Data Protection Officer on health data storage and transfers outside the European Union.
  5. Complete a vendor qualification pack and security questionnaire before the buyer's procurement team asks twice.
  6. Draft service level and data ownership clauses that a pharma legal team accepts without reopening.
  7. Scope a pilot project so its results can be filed in the buyer's validation records.

What the company gets

  • Your vendor qualification files reach European procurement complete, so approvals stop waiting on missing documents.
  • Your product team knows which software falls under the Medical Device Regulation before a launch plan is built on the wrong class.
  • Your sales team answers data protection and validation questions in the meeting, so deals stop stalling between meetings.
  • You keep audit-ready validation records that a national authority inspector or a customer auditor can read without a call to your engineers.

The evidence: questionnaire, training record, certificate

EU GMP Chapter 2, section 2.11, and 21 CFR 211.25 both ask for training that is documented and shown to work. This is what each learner leaves behind.

A recorded questionnaire per module

Every one of the 12 modules ends with a multiple-choice questionnaire. The result is recorded per person with a timestamp, whichever of the three lengths the person listened to.

A per-person training record

The export lists each learner, each module, the result and the date, which is the training record EU GMP Chapter 2 and 21 CFR 211.25 ask you to keep and the first thing an inspector asks for.

A certificate per learner

Name, company, course, hours, the guideline version taught and the date. It documents in-company training; it is not a professional qualification or an accreditation.

Your pass mark, your rule

There is no fixed pass mark. Your quality or human-resources manager decides what counts as passed and when a module is retaken, exactly as your training procedure says.

Delivered within 72 hours of payment, with the workbook, the full transcript and a source for every fact in the audio.

How long it takes, by who is listening

Nobody spends a day in a classroom. Every module exists in three lengths; a person takes the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Briefing2 h10 min a module, for executives, sales and anyone who must know the rules, not run them
Standard5 h25 min a module, for regulatory, quality and business-development staff
Expanded10 h50 min a module, for technical staff who run the procedure day to day
Who takes this courseLengthTotal time
Owner, CEO and boardBriefing2 h
Business development and export salesBriefing2 h
Regulatory affairsStandard5 h
Quality assurance and Qualified PersonStandard5 h

Course outline: 12 modules

12 modules. Under each title are the three things the listener can do afterwards; the audio itself runs 10 to 50 minutes depending on the length chosen.

  1. 1Identify who decides on software at a European pharma company

    • Why the quality head often holds the veto on a GxP system, and how to reach that person first.
    • How to tell the computerised system owner from the budget holder before you book the second meeting.
    • What the buyer's company size and site structure change about who signs the purchase.
  2. 2Prove your software meets EU GxP rules, Annex 11 and GAMP 5

    • How to show a quality manager that your audit trail meets Annex 11, clause 9, before they ask.
    • The GAMP 5 software category that decides how much validation your buyer expects from you.
    • What to put on the table when Annex 11, clause 3, sends your buyer to audit you as a supplier.
  3. 3Answer General Data Protection Regulation questions from pharma buyers

    • How to answer the Data Protection Officer on where patient data sits without calling your lawyer.
    • Why pseudonymised trial data still counts as personal data under Recital 26.
    • What Chapter V transfer rules mean when your servers or support staff sit in Türkiye.
  4. 4Classify your artificial intelligence under the EU Medical Device Regulation

    • How to read Rule 11 of Annex VIII to find your software's risk class before a buyer asks.
    • How to test your algorithm's intended purpose against the Medical Device Coordination Group guidance.
    • What to do when your software falls under the In Vitro Diagnostic Regulation instead.
  5. 5Shape your pitch around what European compliance teams ask first

    • How to open the demo with the validation answers so the GxP objection never comes.
    • The one-page compliance summary that lets a quality manager treat you as a peer, not a software seller.
    • What to show on screen when a buyer asks how a record could be changed without a trace.
  6. 6Earn the trust of European quality, IT and legal stakeholders

    • How to adjust your tone for German, French and British buyers without losing your own style.
    • Why admitting a known gap early keeps a quality manager on your side.
    • When pressing for a quick close costs you the deal, and when a firm date helps.
  7. 7Answer cybersecurity and cloud hosting reviews with documents ready

    • How to use your International Organization for Standardization 27001 certificate in a security review.
    • The data residency answer a pharma IT reviewer accepts for European cloud hosting.
    • Why the second Network and Information Security Directive puts your hosting in your buyer's risk review.
  8. 8Pass European procurement cycles and vendor qualification

    • How to map a large drugmaker's procurement steps from first request to approved supplier status.
    • The vendor qualification pack to have in hand before the first meeting, not after the request.
    • Why one half-filled security questionnaire sends your approval to the back of the queue.
  9. 9Prepare your software and records for European audits and inspections

    • How to hand an auditor the validation evidence they ask for from one organised folder.
    • What to say when an inspector asks how a software change was assessed, tested and released.
    • The records that show an inspector your data stayed intact from entry to archive.
  10. 10Draft contracts and service level agreements European buyers sign

    • How to word licence and intellectual property terms so legal review does not reopen them.
    • The service level agreement measures a pharma IT director asks for: uptime, response and restore times.
    • Why a vague data ownership clause stalls signature, and the wording that ends the delay.
  11. 11Run pilot projects that meet regulatory expectations

    • How to scope a proof of concept so the result counts as evidence for the buyer's validation file.
    • The success measures that let a European client approve the move from pilot to full rollout.
    • What to do when a pilot scope drifts toward features and away from the compliance goals.
  12. 12Build a phased European market entry plan for your software

    • How to pick the first European country by regulator, language and buyer reach, not by guesswork.
    • The official sources that tell your product team when EU rules change, before a buyer does.
    • Why a phased rollout beats a pan-European launch for a vendor starting from Türkiye.
The founders

One of us was inspected. The other one pays for the training.

Every claim below is sourced on the about page: the medicines register, the Lithuanian Pharmaceutical Union board list, the university directory.

Justina Krukonytė-Racz

Justina Krukonytė-Racz

Co-founder. Licensed pharmacist.

GDPResponsible PersonWarehouse & logistics

Licensed pharmacist. Responsible Person at Tamro (PHOENIX group), where she led the GDP set-up of the distribution centre.

The Responsible Person is the named person the regulator holds accountable for every pallet that leaves the building.

She writes the modules around the procedures a GDP inspection checks. Board member of Lithuanian Pharmaceutical Union.

Listed in the Lithuanian medicines register as Pharmacist.

Prof. Ben Racz

Prof. Ben Racz

Co-founder. Builds the platform and is responsible for delivery, records and pricing.

Platform & deliveryQuantitative researchCarnegie Mellon

He was Professor of the Practice at the College of Engineering at Carnegie Mellon University, where he taught Advanced Quantitative Finance and Algorithmic Trading to MSc students.

He is the founder and Managing Director of Algorithmic Sciences, a scientific research and consulting firm. Earlier he co-founded a data-driven growth consultancy, a data-science based wholesale trading company and an information security firm.

More about Ben at benracz.com

Questions about this course

Is there a certificate?

Yes. Every learner who finishes the course receives a certificate in their own name, and every module ends with a recorded multiple-choice questionnaire, so the certificate sits on top of a per-person training record. The certificate documents in-company training; it is not a professional qualification or an accreditation, and your quality or human-resources manager sets the pass mark and decides when a module is retaken.

How long does the course take?

12 modules, each in three lengths: a 10-minute briefing, a 25-minute standard run and a 50-minute expanded walk-through. The whole course takes 2 h in the briefing length and 10 h in the expanded length. People take the length their role needs, and every length ends with the same recorded questionnaire, so the training record is complete either way.

Who should take this course?

It is written for Türkiye, Pharma software and AI vendor. Owners, managers and sales staff hear the briefing length, regulatory, quality and business-development staff take the standard run, and the people who run the procedure every day get the expanded version. One licence covers one named person on this course for a year, so the same title can be rolled out across a whole team at once.

Is this training accepted as a GMP training record by an auditor?

EU GMP Chapter 2 and 21 CFR 211.25 require documented, effective training, and that is what the course produces: a recorded multiple-choice result per module and per person, a certificate per learner and a transcript of what was taught. No provider can promise acceptance by a specific inspector; the record is built to answer what inspectors ask for, and your quality manager decides the pass mark.

How is it delivered and how fast?

The course arrives as audio files with a companion workbook, a full transcript and the questionnaire per module, within 72 hours of your payment arriving. You host the files on your own system or share them as you like; there is no platform to log into and no learner management system to set up. The free sample module arrives on request, before any purchase.

What does it cost per learner?

The list price is 9 euros per module, per learner, per year, so this course is 108 euros for one person for twelve months. The price per learner falls as more people take the same course: 10 learners pay 10 percent less and the discount keeps growing to 50 percent at 1000 learners. Type a number on the price panel and the yearly total appears.

Get this course for your team

One licence is one person on this course for a year. All three lengths, the workbook, the certificate and the training record are included in every purchase. Pick how many people, add it to the cart, and you have an invoice in your inbox.

Free sample module

Hear one full module before you spend a cent. Send your company and the role you want trained, and a complete sample module comes back with its workbook and transcript.

Connect on WhatsApp

or email [email protected], or ask for a written quote for your team